526
Views
36
CrossRef citations to date
0
Altmetric
Drug Evaluations

Oral salmon calcitonin – pharmacology in osteoporosis

, , &
Pages 1617-1629 | Published online: 11 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pegah Varamini & Istvan Toth. (2016) Recent advances in oral delivery of peptide hormones. Expert Opinion on Drug Delivery 13:4, pages 507-522.
Read now
Ronald C Hamdy & Dane N Daley. (2012) Oral calcitonin. International Journal of Women's Health 4, pages 471-479.
Read now

Articles from other publishers (34)

Ashref Kayed, Simone Anna Melander, Suheb Khan, Kim Vietz Andreassen, Morten Asser Karsdal & Kim Henriksen. (2023) The Effects of Dual GLP-1/Glucagon Receptor Agonists with Different Receptor Selectivity in Mouse Models of Obesity and Nonalcoholic Steatohepatitis. Journal of Pharmacology and Experimental Therapeutics 384:3, pages 406-416.
Crossref
Dhrumi Patel & Sarika Wairkar. (2022) Bone regeneration in osteoporosis: opportunities and challenges. Drug Delivery and Translational Research 13:2, pages 419-432.
Crossref
Russell T. Turner, Lara H. Sattgast, Vanessa A. Jimenez, Kathleen A. Grant & Urszula T. Iwaniec. (2021) Making Sense of the Highly Variable Effects of Alcohol on Bone. Clinical Reviews in Bone and Mineral Metabolism 19:1-4, pages 1-13.
Crossref
Yuxue Cao, Prarthana Rewatkar, Ran Wang, Sumaira Z. Hasnain, Amirali Popat & Tushar Kumeria. (2021) Nanocarriers for oral delivery of biologics: small carriers for big payloads. Trends in Pharmacological Sciences 42:11, pages 957-972.
Crossref
Zhi ZhengCuiyun YuHua Wei. (2021) Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment. Tissue Engineering Part B: Reviews 27:5, pages 430-454.
Crossref
Changjun Chen, Mohammed Alqwbani, Jie Zhao, Ruitong Yang, Songgang Wang & Xin Pan. (2021) Effects of Teriparatide versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:5, pages 932-942.
Crossref
Pawel Szulc, Douglas C. Bauer & Richard Eastell. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1545 1588 .
Wale Johnson Adeyemi & Luqman Aribidesi Olayaki. (2018) Synergistic and non-synergistic effects of salmon calcitonin and omega - 3 fatty acids on antioxidant, anti-inflammatory, and haematological indices in diabetic rats. Biomedicine & Pharmacotherapy 99, pages 867-875.
Crossref
Kian Kamgar-Parsi, James Tolchard, Birgit Habenstein, Antoine Loquet, Akira Naito & Ayyalusamy Ramamoorthy. (2017) Structural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation. Israel Journal of Chemistry 57:7-8, pages 634-650.
Crossref
Daniel S. Nielsen, Nicholas E. Shepherd, Weijun Xu, Andrew J. Lucke, Martin J. Stoermer & David P. Fairlie. (2017) Orally Absorbed Cyclic Peptides. Chemical Reviews 117:12, pages 8094-8128.
Crossref
Omar Faour & Jacques Gilloteaux. (2017) Calcitonin: Survey of new anatomy data to pathology and therapeutic aspects. Translational Research in Anatomy 6, pages 4-15.
Crossref
Morten Asser Karsdal, Bente Juul Riis, Nozer Mehta, William Stern, Ehud Arbit, Claus Christiansen & Kim Henriksen. (2015) Lessons learned from the clinical development of oral peptides. British Journal of Clinical Pharmacology 79:5, pages 720-732.
Crossref
Gary WalshGary Walsh. 2015. Proteins. Proteins 233 255 .
Ana Fortuna, Gilberto Alves, Ana Serralheiro, Joana Sousa & Amílcar Falcão. (2014) Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 8-27.
Crossref
Andrea Bortolato, Andrew S Doré, Kaspar Hollenstein, Benjamin G Tehan, Jonathan S Mason & Fiona H Marshall. (2014) Structure of Class B GPCRs: new horizons for drug discovery. British Journal of Pharmacology 171:13, pages 3132-3145.
Crossref
Kim Vietz Andreassen, Sara Toftegaard Hjuler, Sebastian G. Furness, Patrick M. Sexton, Arthur Christopoulos, Olivier Nosjean, Morten Asser Karsdal & Kim Henriksen. (2014) Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias. PLoS ONE 9:3, pages e92042.
Crossref
Odile E. Levy, Carolyn M. Jodka, Shijun Steven Ren, Lala Mamedova, Abhinandini Sharma, Manoj Samant, Lawrence J. D’Souza, Christopher J. Soares, Diane R. Yuskin, Li Jenny Jin, David G. Parkes, Krystyna Tatarkiewicz & Soumitra S. Ghosh. (2014) Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action. PLoS ONE 9:2, pages e87704.
Crossref
J. Varshosaz, M. Minaiyan & M. Forghanian. (2014) Prolonged Hypocalcemic Effect by Pulmonary Delivery of Calcitonin Loaded Poly(Methyl Vinyl Ether Maleic Acid) Bioadhesive Nanoparticles. BioMed Research International 2014, pages 1-13.
Crossref
Robert A. Overman, Mrudula Borse & Margaret L. Gourlay. (2013) Salmon Calcitonin Use and Associated Cancer Risk. Annals of Pharmacotherapy 47:12, pages 1675-1684.
Crossref
Michael R. McClung & Cristiano A. F. Zerbini. 2013. Osteoporosis. Osteoporosis 211 226 .
Nelson B. Watts. 2013. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 408 411 .
Saida Mebarek, Abdelkarim Abousalham, David Magne, Le Do, Joanna Bandorowicz-Pikula, Slawomir Pikula & René Buchet. (2013) Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations. International Journal of Molecular Sciences 14:3, pages 5036-5129.
Crossref
Mathew P. RobinPaul WilsonAnne B. MabireJenny K. KiviahoJeffery E. Raymond, David M. HaddletonRachel K. O’Reilly. (2013) Conjugation-Induced Fluorescent Labeling of Proteins and Polymers Using Dithiomaleimides. Journal of the American Chemical Society 135:8, pages 2875-2878.
Crossref
Pawel Szulc & Douglas C. Bauer. 2013. Osteoporosis. Osteoporosis 1573 1610 .
Pawel Szulc. (2012) The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clinical Biochemistry 45:12, pages 907-919.
Crossref
Sam Maher, Katie B. Ryan, Tauseef Ahmad, Caitriona M. O'driscoll & David J. Brayden*. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers 39 62 .
Randall J. Mrsny. (2012) Oral drug delivery research in Europe. Journal of Controlled Release 161:2, pages 247-253.
Crossref
Pingping Chen-An, Kim Vietz Andreassen, Kim Henriksen, Yadong Li, Morten Asser Karsdal & Anne-Christine Bay-Jensen. (2012) The Inhibitory Effect of Salmon Calcitonin on Tri-Iodothyronine Induction of Early Hypertrophy in Articular Cartilage. PLoS ONE 7:6, pages e40081.
Crossref
Charles R. Robertson, Timothy H. Pruess, Erin Grussendorf, H. Steve White & Grzegorz Bulaj. (2012) Generating Orally Active Galanin Analogues with Analgesic Activities. ChemMedChem 7:5, pages 903-909.
Crossref
Michael J. Maricic. (2012) Oral Calcitonin. Current Osteoporosis Reports 10:1, pages 80-85.
Crossref
S. Silverman & C. Christiansen. (2012) Individualizing osteoporosis therapy. Osteoporosis International 23:3, pages 797-809.
Crossref
Rui Huang, Subramanian Vivekanandan, Jeffrey R. Brender, Yuki Abe, Akira Naito & Ayyalusamy Ramamoorthy. (2012) NMR Characterization of Monomeric and Oligomeric Conformations of Human Calcitonin and Its Interaction with EGCG. Journal of Molecular Biology 416:1, pages 108-120.
Crossref
Mathew W. JonesRachel A. StricklandFelix F. SchumacherStephen CaddickJames. R. BakerMatthew I. GibsonDavid M. Haddleton. (2012) Polymeric Dibromomaleimides As Extremely Efficient Disulfide Bridging Bioconjugation and Pegylation Agents. Journal of the American Chemical Society 134:3, pages 1847-1852.
Crossref
Kim Henriksen, Claus Christiansen & Morten Asser Karsdal. (2011) Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning. Drug Discovery Today 16:21-22, pages 967-975.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.